TrianglePUBLICATIONS · 36239316
A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Neuro Oncol
- Publication date
- 2023 Apr 6
- First author
- Green K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Green K
- type
- Author
- name
- Panagopoulou P
- type
- Author
- name
- D'Arco F
- type
- Author
- name
- O'Hare P
- type
- Author
- name
- Bowman R
- type
- Author
- name
- Walters B
- type
- Author
- name
- Dahl C
- type
- Author
- name
- Jorgensen M
- type
- Author
- name
- Patel P
- type
- Author
- name
- Slater O
- type
- Author
- name
- Ahmed R
- type
- Author
- name
- Bailey S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Green K
- type
- Author
- name
- Panagopoulou P
- type
- Author
- name
- D'Arco F
- type
- Author
- name
- O'Hare P
- type
- Author
- name
- Bowman R
- type
- Author
- name
- Walters B
- type
- Author
- name
- Dahl C
- type
- Author
- name
- Jorgensen M
- type
- Author
- name
- Patel P
- type
- Author
- name
- Slater O
- type
- Author
- name
- Ahmed R
- type
- Author
- name
- Bailey S
- type
- Author
- bibliography ids
- nci-bib-341deaaccc9a1ae0483956d7
- book metadata
- content sha256
- 2b81551d13a9fdeb72677bab0a792ab05215798ac2aa74862d6e586fe3ca7b52
- document type
- citation
- dois
- 10.1093/neuonc/noac223
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36239316
- immutable id
- pubmed:36239316@2b81551d13a9fdeb72677bab0a792ab05215798ac2aa74862d6e586fe3ca7b52
- journal
- abbreviation
- Neuro Oncol
- issn electronic
- 1523-5866
- issn print
- 1522-8517
- issue
- 4
- name
- Neuro-oncology
- nlm unique id
- 100887420
- pages
- 774-785
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36239316
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- b692538e31c8fff1e7efb6b6fb90ee43d604c6b9230138f677d39ab390fa1073
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Apr 6
- precision
- day
- year
- 2023
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes.
Preserved source evidence · Not medical advice